United States

Drug extends life of younger women with advanced breast cancer, study says

(CNN)Younger women suffering from a common form of advanced breast cancer have experienced significantly improved survival rates when treated with a drug that targets cancer cells, according to the findings of an international clinical trial.The study was conducted among 672 women under the age of 59 who received a drug called ribociclib, in combination with a common form of hormone therapy. Seventy percent of the women who took the combination therapy were alive after 42 months according to the findings, compared to 46% for women who were treated with only the hormone therapy and a placebo.This, the researchers said, corresponded to a 29% lower risk of death in patients receiving the combination therapy. The results were presented at the ...